论文部分内容阅读
目的:探讨欣母沛在预防高危产妇产后出血的价值及应用时机。方法:将122例存在产后出血高危因素孕妇随机均分为欣母沛A组与欣母沛B组,选择未使用欣母沛药物高危孕妇61例编入常规组.欣母沛A组在产后出血且止血无效时使用欣母沛.欣母沛B组在胎儿娩出后立即使用欣母沛.对比三组患者间产后2 h,24 h出血量及产后出血率。结果:常规组在术中出血量、产后2 h出血量及产后24 h出血量均明显高于欣母沛A组与欣母沛B组(p<0.01);欣母沛A组在术中出血量、产后2h出血量及产后24 h出血量均明显高于欣母沛B组(P<0.01)。欣母沛B组产后出血率低于欣母沛A组(P<0.05).结论:欣母沛相比缩宫素具有更好防治产后出血效果。对于具有产后出血高危因素产妇,应在胎儿娩出后立即使用欣母沛.
Objective: To explore the value and application of Xin-Pei-Pei in preventing postpartum hemorrhage in high-risk maternal women. Methods: A total of 122 pregnant women with high risk of postpartum hemorrhage were randomly divided into Xinma Pei Group A and Xinma Pei Group B. Sixty-one pregnant women who did not use Xinmi Pei were enrolled in routine group. Bleeding and stop bleeding when the use of Xin Pei. Yan Xin Pei B group immediately after delivery of the use of Yan Xin Pei. Comparison of three groups of patients postpartum 2 h, 24 h and postpartum hemorrhage bleeding rate. Results: The amount of bleeding during operation, the amount of bleeding at 2 h postpartum and the amount of bleeding at 24 h postpartum were significantly higher than those of Xinma Pei A and Xin Ma Pei B (P <0.01) The amount of bleeding, 2h postpartum hemorrhage and 24 h postpartum hemorrhage were significantly higher than that of Yanbian Pei B group (P <0.01). The rate of postpartum hemorrhage in group B was lower than that in group A (P <0.05) .Conclusion: Compared with oxytocin, group Xinmaopei has a better effect in preventing postpartum hemorrhage. For maternal high risk factors for postpartum hemorrhage, should be used immediately after the delivery of Yan Xin Pei.